Literature DB >> 29054571

Associations of DC-SIGN (CD209) promoter -336G/A polymorphism (rs4804803) with dengue infection: A systematic review and meta-analysis.

Noel Pabalan1, Suwit Chaisri2, Sompong Tabunhan2, Achara Phumyen2, Hamdi Jarjanazi3, Theodore S Steiner4.   

Abstract

BACKGROUND AND AIM: Dengue virus entry into a host is associated with a cell surface protein, DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin). A common CD209-336G/A (rs4804803) polymorphism in DC-SIGN may affect severity of dengue virus infection (DEN) and incidence of dengue fever (DF) or the more severe dengue hemorrhagic fever (DHF). However, the reported associations of these two outcomes and CD-209 have been inconsistent, which prompted a meta-analysis to obtain more precise estimates.
METHODS: A literature search yielded seven case-control studies. We calculated pooled odds ratios (OR) and 95% confidence intervals using standard genetic models. Outlier treatment examined sources of potential heterogeneity. Subgroup analysis was performed for ethnicity and age.
RESULTS: All significant outcomes for association indicating reduced risk were pegged at P=0.007-0.05. In the homozygous and recessive models, these were observed in the overall analysis (OR 0.52-0.55), and subgroups of South/Central Americans (OR 0.30-0.32) and school-age children (OR 0.44) in the DHF analysis as well as the codominant model among Asians in DF (OR 0.59). These significant outcomes are strengthened by their non-heterogeneity (P>0.10) and robustness of the effects. Most pooled effects in DF and DEN were variable.
CONCLUSIONS: The DC-SIGN -336G/A polymorphism significantly affects DHF and DF incidence with the effect more pronounced in certain analyzed patient subgroups.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DC-SIGN (CD209)-336G/A; Dengue virus infection; Meta-analysis; Polymorphism

Mesh:

Substances:

Year:  2017        PMID: 29054571     DOI: 10.1016/j.actatropica.2017.10.017

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  5 in total

1.  A novel CD209 polymorphism is associated with rheumatoid arthritis patients in Taiwan.

Authors:  Hua-Chen Chan; Shu-Chen Wang; Chia-Hui Lin; Yuan-Zhao Lin; Ruei-Nian Li; Jeng-Hsien Yen
Journal:  J Clin Lab Anal       Date:  2021-04-01       Impact factor: 2.352

Review 2.  Early Events in Japanese Encephalitis Virus Infection: Viral Entry.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  Pathogens       Date:  2018-08-13

3.  In silico screening and identification of deleterious missense SNPs along with their effects on CD-209 gene: An insight to CD-209 related-diseases.

Authors:  Mohib Ullah Kakar; Muhammad Matloob; Rongji Dai; Yulin Deng; Kifayat Ullah; Ihsan Ullah Kakar; Ghulam Khaliq; Muhammad Umer; Zhoaib Ahmed Bhutto; Sarfarz Ali Fazlani; Muhammad Zubair Mehboob
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

4.  CD209 and Not CD28 or STAT6 Polymorphism Mediates Clinical Malaria and Parasitemia among Children from Nigeria.

Authors:  Olanrewaju B Morenikeji; Jessica L Metelski; Megan E Hawkes; Anna L Capria; Brooke N Seamans; Catherine O Falade; Olusola Ojurongbe; Bolaji N Thomas
Journal:  Microorganisms       Date:  2020-01-23

5.  Genetic risk for dengue hemorrhagic fever and dengue fever in multiple ancestries.

Authors:  Guillaume Pare; Binod Neupane; Sasha Eskandarian; Eva Harris; Scott Halstead; Lionel Gresh; Guillermina Kuan; Angel Balmaseda; Luis Villar; Elsa Rojas; Jorge E Osorio; Dang Duc Anh; Aruna Dharshan De Silva; Sunil Premawansa; Gayani Premawansa; Ananda Wijewickrama; Ivette Lorenzana; Leda Parham; Cynthia Rodriguez; Ildefonso Fernandez-Salas; Rosa Sanchez-Casas; Esteban E Diaz-Gonzalez; Khin Saw Aye; Win Lai May; Min Thein; Filemon Bucardo; Yaoska Reyes; Patricia Blandon; Kenji Hirayama; Lan Weiss; Pardeep Singh; Jennifer Newton; Mark Loeb
Journal:  EBioMedicine       Date:  2020-01-02       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.